A practical reference on 长效肽设计: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Semaglutide is a synthetic peptide of thirty-one amino acids that shares roughly ninety-four percent sequence identity with human glucagon-like peptide-1. Two substitutions resist enzymatic cleavage by dipeptidyl peptidase-4, and a fatty diacid side chain attached through a linker promotes binding to serum albumin. That albumin binding slows renal clearance and extends the circulating half-life from minutes to approximately one week. The structural changes are well established in the published literature. Whether the same modifications affect receptor signalling bias in ways that matter clinically remains an open question.
Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.
The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.
The sequence incorporates alpha-aminoisobutyric acid at position 8, replacing the alanine found in the natural hormone. This substitution blocks the primary DPP-4 recognition site and contributes most of the enzymatic stability. Albumin binding further protects the peptide and reduces the frequency of administration required to maintain active plasma levels. Because the fatty acid chain increases lipophilicity, the compound is formulated as a solution rather than a simple aqueous buffer. Researchers describe the design as an incremental optimization of earlier GLP-1 analogs rather than a wholly new scaffold.
Reported molecular weight is approximately 4113.6 daltons for the free base, and the peptide is supplied as a lyophilized powder or in buffered liquid form depending on the intended use. It is freely soluble in water when formulated with appropriate excipients, though the unconjugated peptide shows limited stability at neutral pH over long periods. Analytical characterization typically relies on reversed-phase high-performance liquid chromatography and mass spectrometry. Purity specifications for research-grade material commonly exceed ninety-five percent by area. Isotopic and impurity profiles differ between suppliers.
Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.
| Property | Value | Notes |
|---|---|---|
| Molecular class | 31-amino-acid peptide | Modified glucagon-like peptide-1 analogue |
| Molecular mass | approximately 4114 Da | Calculated for the free peptide backbone |
| Appearance | white to off-white powder | Typical of purified lyophilised peptide batches |
| Solubility class | freely soluble in water | Aqueous solubility improves at slightly alkaline pH |
| Typical storage | -20 degrees Celsius, dry, dark | Protect from repeated freeze-thaw cycles |
Lyophilized semaglutide powder is typically held at minus twenty degrees Celsius for long-term storage. At that temperature, solid-state degradation reactions proceed slowly and the peptide remains intact for extended periods. Repeated freeze-thaw cycles are best avoided because they promote aggregation and can shift the proportion of monomeric peptide present. Working aliquots are often prepared so that each portion is thawed only once, and desiccant is placed inside the vial to limit moisture uptake.
Identity and purity are usually assessed by reverse-phase high-performance liquid chromatography coupled to mass spectrometry. Retention time and observed mass are compared against a reference standard run under identical conditions. Impurity profiles reveal deamidation products, oxidized methionine variants, and truncated fragments that arise during synthesis or storage. Peptide mapping through enzymatic digestion confirms the primary sequence, while amino acid analysis offers an independent check on overall composition.
Stability studies examine how temperature, pH, and moisture influence degradation rates over time. In aqueous solution, hydrolysis and deamidation accelerate as pH moves away from mildly acidic conditions. Light exposure and residual metal ions can also trigger oxidation of susceptible residues. Accelerated aging at elevated temperature is used to estimate shelf life, though extrapolation to room temperature carries uncertainty because individual degradation pathways do not always scale predictably.
该分子作为 GLP-1 受体的选择性激动剂发挥作用，受体属于 B 类 G 蛋白偶联受体家族，激活后经 Gs 通路提升细胞内环腺苷酸水平。在胰腺 β 细胞，信号促进葡萄糖依赖性的胰岛素释放，血糖偏低时该作用明显减弱。在胰岛 α 细胞，胰高血糖素分泌受到抑制。中枢神经系统与胃肠道同样存在受体表达，相应信号参与食欲调节以及胃排空速率的降低。
皮下注射后吸收相对缓慢，绝对生物利用度约为百分之八十九，血药浓度峰值通常出现在给药后一到三天。与白蛋白结合使清除减慢，终末半衰期约为一百六十五小时，接近一周。连续给药约四到五周后达到稳态暴露水平。表观分布容积约为每千克零点二五升，血浆蛋白结合率超过百分之九十九。代谢以蛋白水解切割和脂肪二酸侧链的 β-氧化为主，相关产物主要经尿液与粪便排出。
序列层面的改动同时解决了两个问题，即酶解稳定性与肾脏清除速度。天然 GLP-1 在循环中的半衰期仅约两分钟，主要被二肽基肽酶-4 迅速灭活。酰化侧链与白蛋白的可逆结合形成循环储库，使分子缓慢释放并持续激活受体。这种设计思路后来被广泛用于同类长效肽的开发，属于该类药物化学改造的典型范式。
The Sanger Institute About the 1958 Nobel Prize About the 1980 Nobel Prize Fred Sanger 2001 Video Documentary by The Vega Science Trust Portraits of Frederick Sanger at the National Portrait Gallery, London Frederick Sanger interviewed by Alan Macfarlane, 24 August 2007 (video), also available on Video on YouTube. Duration 57 minutes. Frederick Sanger archive collection – Wellcome Library finding aid for the digitised collection. Frederick Sanger on Nobelprize.org
=== Novel mAb development technology === Several monoclonal antibody technologies were developed in the period from the 1970s to the late 2010s, such as phage display, single B cell culture, single cell amplification from various B cell populations and single plasma cell interrogation technologies. Different from traditional hybridoma technology, the more recent technologies use molecular biology techniques to amplify the heavy and light chains of the antibody genes by PCR and produce in either bacterial or mammalian systems with recombinant technology. One of the advantages of the new technologies is their applicability to multiple animals, such as rabbit, llama, chicken and other common experimental animals in the laboratory.
== Publications == Marley, Christopher (September 1, 2008). Pheromone: The Insect Artwork of Christopher Marley. Pomegranate Communications. ISBN 978-0764946196. Marley, Christopher (April 14, 2015). Biophilia. Harry N. Abrams. ISBN 978-1419715617. Marley, Christopher (January 1, 2023). Exquisite Creatures: A Dialogue with Art, Nature, and Science. Christopher Marley Studio. ISBN 979-8986360805.
=== Generic names === Benorterone is the generic name of the drug and its INNTooltip International Nonproprietary Name and USANTooltip United States Adopted Name. It is also known by its developmental code names SKF-7690 and FC-612.
Sources: en.wikipedia.org
=== START college savings plan === In 1997, Louisiana launched its Student Tuition Assistance and Revenue Trust Savings Program to allow people to start a 529 plan to save for their children's education. As treasurer, Kennedy expanded five new investment options to give parents the choice of investing in the stock market in addition to the fixed returned securities options. He also put these investment options online to make it easier for parents to watch and manage their investments. During Kennedy's tenure, Louisiana's START program was ranked fifth-best in the nation.
The Selous Scouts was a special forces unit of the Rhodesian Army that operated during the Rhodesian Bush War from 1973 until the reconstitution of the country as Zimbabwe in 1980. It was mainly responsible for infiltrating the black majority population of Rhodesia and collecting intelligence on insurgents so that they could be attacked by regular elements of the security forces. The unit did this by forming small teams that posed as insurgents and usually included captured insurgents. Over time, the Selous Scouts increasingly attacked insurgents themselves and operated in the countries that neighboured Rhodesia. The unit developed a reputation for brutality and was responsible for attacking and killing civilians. The Selous Scouts were also involved in the Rhodesian chemical and biological weapons programme and used poisons and biological agents in some of its operations. The methods used by the unit led to the deaths of large numbers of insurgents, but proved counter-productive as they further alienated the black majority population from the white minority Rhodesian government and increased international opposition to the regime. Following the disbandment of the Selous Scouts after Rhodesia's transition to Zimbabwe, many of its members were recruited into the Apartheid-era South African security forces. They contributed to the adoption of the Selous Scouts' methods by the South African Defence Force and South African Police, and some took part in operations to undermine the government of Zimbabwe.
A distinguishing feature of SARS‑CoV‑2 is its incorporation of a polybasic site cleaved by furin, which appears to be an important element enhancing its virulence. It was suggested that the acquisition of the furin-cleavage site in the SARS-CoV-2 S protein was essential for zoonotic transfer to humans. The furin protease recognises the canonical peptide sequence RX[R/K] R↓X where the cleavage site is indicated by a down arrow and X is any amino acid. In SARS-CoV-2 the recognition site is formed by the incorporated 12 codon nucleotide sequence CCT CGG CGG GCA which corresponds to the amino acid sequence P RR A. This sequence is upstream of an arginine and serine which forms the S1/S2 cleavage site (P RR A R↓S) of the spike protein. Although such sites are a common naturally-occurring feature of other viruses within the Subfamily Orthocoronavirinae, it appears in few other viruses from the Beta-CoV genus, and it is unique among members of its subgenus for such a site. The closest relatives to SARS-CoV-2, including BANAL-20-52, RaTG13, Pangolin P4L, and SARS-CoV-1, lack the RRAR insertion. The furin cleavage site PRRAR↓ is highly similar to that of the feline coronavirus, an alphacoronavirus 1 virus. Viral genetic sequence data can provide critical information about whether viruses separated by time and space are likely to be epidemiologically linked. With a sufficient number of sequenced genomes, it is possible to reconstruct a phylogenetic tree of the mutation history of a family of viruses.
Sources: en.wikipedia.org
Some 238U atoms, however, could absorb two additional neutrons (for a total of 17), resulting in 255Es, as well as in the 255Fm isotope of another new element, fermium. The discovery of the new elements and the associated new data on multiple neutron capture were initially kept secret on the orders of the U.S. military until 1955 due to Cold War tensions and competition with Soviet Union in nuclear technologies. However, the rapid capture of so many neutrons would provide needed direct experimental confirmation of the r-process multi-neutron absorption needed to explain the cosmic nucleosynthesis (production) of certain heavy elements (heavier than nickel) in supernovas, before beta decay. Such a process is needed to explain the existence of many stable elements in the universe. Meanwhile, isotopes of element 99 (as well as of new element 100, fermium) were produced in the Berkeley and Argonne laboratories, in a nuclear reaction between nitrogen-14 and uranium-238, and later by intense neutron irradiation of plutonium or californium:
=== „Gott ist schön“ (Dissertation 1998) === A parallel (including excursions into the scholarly realm) is discernable here with Kermani's narratively oriented 1999 dissertation „Gott ist schön“ (God is Beautiful). The dissertation, after all, investigates the (musical) aesthetics of the Koran and contains a subchapter entitled “Those Killed by the Koran“.
== Role in cell signaling == Protein quaternary structure also plays an important role in certain cell signaling pathways. The G protein-coupled receptor pathway involves a heterotrimeric protein known as a G protein. G proteins contain three distinct subunits known as the G-alpha, G-beta, and G-gamma subunits. When the G protein is activated, it binds to the G protein-coupled receptor protein and the cell signaling pathway is initiated. Another example is the receptor tyrosine kinase (RTK) pathway, which is initiated by the dimerization of two receptor tyrosine kinase monomers. When the dimer is formed, the two kinases can phosphorylate each other and initiate a cell signaling pathway.
== History == The APF was originally a pocket-sized booklet first published in 1902, used by physicians as a drugs reference in Australia. In later editions, rather than simply being a listing of pharmaceuticals, medical and clinical information became incorporated within the publication as well, and eventually the title of the APF was extended to the Australian Pharmaceutical Formulary and Handbook.
Sources: en.wikipedia.org
It is a glucagon-like peptide-1 receptor agonist, often grouped with the incretin mimetics. Its backbone is modified from the human hormone to resist enzymatic degradation and to bind albumin. These two features distinguish it from the native peptide.
No. It shares high sequence identity but carries non-natural modifications that alter its stability and clearance. The naturally occurring hormone is broken down within minutes, while the synthetic analogue circulates far longer.
Attachment to serum albumin reduces renal filtration of the peptide and shields it from enzymatic breakdown. The consequence is a much longer interval between administrations than unmodified peptides allow. The precise contribution of binding affinity to overall duration is still being quantified.
It is a modified version of the natural hormone, with three amino acid changes and a fatty acid side chain added. These edits extend its half-life from minutes to about one week. The core receptor activity is retained.